Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial

IMPORTANCE: Weight loss improves cardiometabolic risk factors in people with overweight or obesity. Intensive lifestyle intervention and pharmacotherapy are the most effective noninvasive weight loss approaches. OBJECTIVE: To compare the effects of once-weekly subcutaneous semaglutide, 2.4 mg vs pla...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JAMA
Главные авторы: Wadden, Thomas A., Bailey, Timothy S., Billings, Liana K., Davies, Melanie, Frias, Juan P., Koroleva, Anna, Lingvay, Ildiko, O’Neil, Patrick M., Rubino, Domenica M., Skovgaard, Dorthe, Wallenstein, Signe O. R., Garvey, W. Timothy
Формат: Artigo
Язык:Inglês
Опубликовано: American Medical Association 2021
Предметы:
Original Investigation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7905697/
https://ncbi.nlm.nih.gov/pubmed/33625476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2021.1831
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы